Sign inGet started

Semba Charles Pauling

Insider CIK 1872863 · DMAC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DMAC DiaMedica Therapeutics Inc A Award deriv2026-06-012026-06-0340,412— $040,412SEC↗
DMAC DiaMedica Therapeutics Inc A Award2026-01-022026-01-063,355$8.42 $28.2K47,963SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2025-06-012025-06-0332,162— $032,162SEC↗
DMAC DiaMedica Therapeutics Inc A Award2025-01-022025-01-035,290$5.34 $28.2K44,608SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2024-06-012024-06-0328,472— $028,472SEC↗
DMAC DiaMedica Therapeutics Inc A Award2024-01-022024-01-029,375$2.80 $26.3K39,318SEC↗
DMAC DiaMedica Therapeutics Inc P Buy2023-06-232023-06-2612,787$3.91 $50.0K29,943SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2023-06-012023-06-0216,968— $016,968SEC↗
DMAC DiaMedica Therapeutics Inc A Award2023-01-032023-01-0317,156$1.53 $26.2K17,156SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2022-06-012022-06-0213,222— $013,222SEC↗
DMAC DiaMedica Therapeutics Inc A Award deriv2021-07-152021-07-1618,786— $018,786SEC↗